Multivalent Flavivirus Vaccine Development Using a Flexible Replicating RNA Platform
This project seeks to develop a novel, bivalent, thermostable self-amplifying RNA vaccine against two flaviviruses (Yellow Fever and Zika) from preclinical studies to GMP manufacturing and a Phase 1 clinical.
Countries
Active Dates
09/01/2019 to 08/31/2024
Faculty Involved